Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 NOK)

NET PROFIT (x1000 NOK)

EMPLOYEES

Share

Xbrane Biopharma AB

Closing information (x1000 NOK)

Closing information 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Turnover 204,940 More Arrow 241,840 Less Arrow 54,502
Financial expenses 37,144 Less Arrow 18,804 Less Arrow 2,172
Earnings before taxes -261,362 Less Arrow -326,225 More Arrow -159,399
EBITDA -188,567 Less Arrow -304,677 More Arrow -150,188
Total assets 868,795 Less Arrow 662,024 Less Arrow 653,167
Current assets 624,861 Less Arrow 467,710 More Arrow 485,749
Current liabilities 554,776 Less Arrow 330,813 Less Arrow 223,774
Equity capital 215,066 Less Arrow 173,568 More Arrow 401,907
- share capital 354,247 Less Arrow 6,770 Less Arrow 5,832
Employees (average) 71 More Arrow 89 Less Arrow 68

Financial ratios

Fiscal year 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Solvency 24.8% More Arrow 26.2% More Arrow 61.5%
Turnover per employee 2,886 Less Arrow 2,717 Less Arrow 802
Profit as a percentage of turnover -127.5% Less Arrow -134.9% Less Arrow -292.5%
Return on assets (ROA) -25.8% Less Arrow -46.4% More Arrow -24.1%
Current ratio 112.6% More Arrow 141.4% More Arrow 217.1%
Return on equity (ROE) -121.5% Less Arrow -188.0% More Arrow -39.7%
Change turnover -41,260 More Arrow 183,471 Less Arrow 54,502
Change turnover % -17% More Arrow 314%
Chg. No. of employees -18 More Arrow 21 Less Arrow 18
Chg. No. of employees % -20% More Arrow 31% More Arrow 36%

Total value of public sale

Fiscal year 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.